Skip to content
Trial Agents

Avantor Performance Materials

Avantor Performance Materials is recorded as a service provider in 1 clinical trial. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.

1distinct trials
1recorded service labels
0trials with learnings

Data snapshot: 2026-10-09 · About the data

Clinical trial experience

Showing 1 of 1 trials · Latest update first

Phase 3 Multicenter, Randomized, Open-label, Active-controlled Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb for Treatment-naïve Subjects With Metastatic Colorectal Cancer With KRAS p.G12C Mutation (CodeBreaK 301)

Sponsor Amgen Inc.

Start (EU)
Latest update
Estimated end

Questions about this trial experience

What services are recorded for Avantor Performance Materials?

The 2026-10-09 snapshot links Avantor Performance Materials to 1 distinct CTIS trials. Recorded services include Equipment Provisioning. These are study-specific roles, not a complete or independently verified capability catalogue.

Which therapeutic areas and study phases are recorded for Avantor Performance Materials?

Therapeutic-area tags are not recorded in this snapshot. Study-phase tags are not recorded. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.

In which countries are trials linked to Avantor Performance Materials conducted?

The linked trials record locations in 18 countries, including Austria, Belgium, Bulgaria, Czechia, Germany. These are trial locations, not confirmed office locations or countries where Avantor Performance Materials delivered services.

What can this page tell me about Avantor Performance Materials's trial experience?

Browse 1 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.

About this data & company names

One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.

Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.

Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Avantor Performance Materials. Legacy brands remain separate unless explicitly matched in the name registry.

View recorded company names
  • Avantor Performance Materials Inc.

Never miss a new clinical trial insight

We continuously analyze new and updated clinical trial data and publish practical, evidence-led reports for clinical leaders.